Today: 1 July 2026
Browse Category

NASDAQ:PGEN 15 August 2025 - 14 May 2026

Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

Precigen Inc. shares surged Thursday morning after revenue came in ahead of Wall Street expectations, buoyed by the company’s inaugural full commercial quarter for Papzimeos—a boost that also sharply narrowed its loss. Precigen surged 14.1% in after-hours trading, hitting $4.74, MarketBeat showed at 08:02 Eastern. First-quarter revenue reached $23.25 million, clearing the Street’s $20.81 million estimate. Loss per share narrowed to 2 cents, beating the anticipated 3-cent loss.
14 May 2026
·
Precigen (PGEN) Soars as PAPZIMEOS Launch, Q3 2025 Earnings and Fresh Analyst Upgrades Ignite Investor Interest

Precigen (PGEN) Soars as PAPZIMEOS Launch, Q3 2025 Earnings and Fresh Analyst Upgrades Ignite Investor Interest

On 14 November 2025, Precigen, Inc. is back in the spotlight. The gene‑therapy specialist’s stock is trading roughly 25–30% higher intraday around $4.90–$5.00, after closing at $3.86 on 13 November, on surging volume of nearly 11 million shares.StockAnalysis+1 The move caps a spectacular 12‑month run in which the stock has delivered well over 300% total return, powered by full FDA approval and U.S. launch of its PAPZIMEOS™ therapy for recurrent respiratory papillomatosis and a wave of bullish post‑earnings commentary.Simply Wall St+1
14 November 2025
···
Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Sources: Original news reports, press releases and scientific publications from Aug 14–15, 2025 fda.gov fiercebiotech.com fiercepharma.com paho.org fiercebiotech.com, as cited above. Each development is attributed to reputable sources including FDA announcements, company press statements, peer-reviewed journals, and expert commentary to ensure accuracy and context.
15 August 2025
···

Stock Market Today

  • UK Defense Shares Jump After Starmer's £15B Plan; Analysts Flag Risks
    July 1, 2026, 8:29 AM EDT. Prime Minister Keir Starmer's outgoing government outlined an extra £15 billion ($19.9 billion) in defense spending for the U.K. over four years, taking annual defense spending to £79.1 billion by 2029, or 2.7% of GDP. The Defence Investment Plan, aimed at bolstering military strength and boosting areas like cybersecurity and AI, sent the FTSE 350 Aerospace & Defense index up almost 5% since Tuesday. BAE Systems, Babcock, and Chemring all moved higher. Analysts see questions ahead, warning limited fiscal space and possible project delays could limit longer-term upside. The sector's five-year run has beaten U.S. rivals, but high valuations and uncertain payoff restrain optimism.
Go toTop